Primary Record
LITHOCHOLIC ACID
- In stock
- 3,640 g
- Purity
- 98.4 %
- CAS
- 434-13-9
Compound Identifiers & Properties
- CAS
- 434-13-9
- PubChem CID
- 9903
- SMILES
- C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C
- Canonical SMILES
- C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Names & Synonyms
- LITHOCHOLIC ACID
- Lithocolic acid
- Lithocholate
- 434-13-9
- 3alpha-Hydroxy-5beta-cholanic acid
- Litocholic acid
- lithocholic-acid
- LITHOCHOLICACID
- 3-Hydroxycholan-24-oic acid
- 3alpha-Hydroxy-5beta-cholan-24-oic acid
- 3alpha-Hydroxycholanic acid
- Acid, Lithocholic
- Isolithocholic acid
- Prestwick_88
- 3-alpha-Hydroxycholanic acid
- Acid, Isolithocholic
- Lithocholic acid CRS
- 5beta-Cholanic acid-3alpha-ol
- 3alpha-Hydroxy-5beta-cholanate
- 4q0a
- CCRIS 363
- NCI-C03861
- 3|A-Hydroxy-5|A-cholanic acid
- Prestwick0_000796
- Prestwick1_000796
- Prestwick2_000796
- Prestwick3_000796
- RefChem:153789
- Spectrum5_002021
- 3alpha-Hydroxy-5beta-cholanoic acid
- Bevacizumab + Trastuzumab
- CHEMBL1478
- 3|A-Hydroxycholanic Acid
- DTXSID6020779
- MFCD00003682
- bmse000686
- D04SLF
- D0K9CR
- DTXCID80779
- UPCMLD-DP153
- 3.alpha.-Hydroxycholanic acid
- HSDB 4113
- UNII-5QU0I8393U
- 3-Hydroxy-5-cholanic acid
- AC1L1U2Z
- cid_9903
- Lithocholic acid, >=95%
- SMEROWZSTRWXGI-HVATVPOCSA-N
- 5QU0I8393U
- BIDD:PXR0054
- SCHEMBL28449
- 3-alpha-Hydroxy-5-beta-cholanic acid
- BSPBio_000932
- GTPL611
- 5-beta-Cholanic acid, 3-alpha-hydroxy-
- CHEBI:16325
- MLS002154006
- 3a-Hydroxy-5ss-cholanic acid
- LITHOCHOLIC ACID [MI]
- EINECS 207-099-1
- SPBio_002871
- NSC683770
- BPBio1_001026
- orb1306119
- 3a-hydroxy-5b-cholan-24-oate
- LITHOCHOLIC ACID [HSDB]
- Ursodeoxycholic Acid EP Impurity C
- 5beta-Cholan-24-oic acid, 3alpha-hydroxy-
- C24H40O3
- NSC 657956
- NSC-683770
- UPCMLD-DP153:001
- (3alpha,5beta)-3-hydroxycholan-24-oic acid
- ERK5-6A18
- NCI-CO-3861
- 3alphahydroxy-5beta-cholanic acid
- BRN 3217757
- CID9903
- 3|A-Hydroxy-5|A-cholanoic Acid
- 5ss--Cholan-24-oic acid-3a-ol
- GLXC-08146
- HMS1570O14
- HMS2097O14
- HMS2269C14
- HMS3714O14
- NSC 683770
- NSC-657956
- 3|A-Hydroxy-5|A-cholan-24-oate
- 3a-hydroxy-5b-cholan-24-oic acid
- HY-B0172
- MSK10393
- ZINC3918156
- 5-beta-Cholan-24-oic acid, 3-alpha-hydroxy-
- 5|A-Cholan-24-oic acid-3|A-ol
- Tox21_201868
- Tox21_302791
- 3a-Hydroxy-5ss-cholan-24-oic acid
- 5.beta.-Cholanic acid-3.alpha.-ol
- BDBM50236238
- EBC-07670
- LMST04010003
- LS-118
- NSC657956
- s4003
- SBB012598
- (3-alpha,5-beta)-3-Hydroxycholan-24-oic acid
- (3a,5b)-3-hydroxy-cholan-24-oate
- 5beta-Cholan-24-oic acid-3alpha-ol
- Cholan-24-oic acid, 3-hydroxy-, (3alpha,5beta)-
- ST069335
- AKOS016010251
- LITHOCHOLIC ACID [EP IMPURITY]
- Lithocholic Acid CRS (L0720800)
- 17beta-(1-Methyl-3-carboxypropyl)etiocholan-3alpha-ol
- 3|A-Hydroxy-5|A-cholan-24-oic acid
- C24-H40-O3
- CCG-220796
- Cholan-24-oic acid, 3-hydroxy-, (3a,5b)-
- CS-2049
- CS-O-05567
- DS-3878
- FL24913
- J1.532F
- ST 24:1;O3
- (3|A,5|A)-3-Hydroxycholan-24-oic Acid
- (3a,5b)-3-Hydroxycholan-24-Oic acid
- 3.alpha.-Hydroxy-5.beta.-cholanic acid
- NCGC00091272-01
- NCGC00091272-04
- NCGC00091272-06
- NCGC00091272-07
- NCGC00091272-08
- NCGC00256451-01
- NCGC00259417-01
- (3a,5b)-3-hydroxy-cholan-24-oic acid
- 17-beta-(1-Methyl-3-carboxypropyl)ethiocholan-3-alpha-ol
- 3.alpha.-Hydroxy-5.beta.-cholanoic acid
- AJ-47431
- CAS-434-13-9
- DA-75041
- M622
- NCI60_028903
- NCI60_030095
- SC-90635
- SMR000112168
- SY105976
- 5.beta.-Cholan-24-oic acid-3.alpha.-ol
- TR-016841
- A8463
- Cholan-24-oic acid, 3-hydroxy-, (3-alpha,5-beta)-
- L0089
- NS00031340
- 4-10-00-00785 (Beilstein Handbook Reference)
- 5-.beta.-Cholanic acid, 3-.alpha.-hydroxy-
- 3.alpha.-Hydroxy-5.beta.-cholan-24-oic acid
- C03990
- EN300-393802
- (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
- 17b-(1-Methyl-3-carboxypropyl)etiocholan-3a-ol
- 5.beta.-Cholan-24-oic acid, 3.alpha.-hydroxy-
- A872700
- F241301
- SR-05000000450
- 17|A-(1-Methyl-3-carboxypropyl)etiocholan-3|A-ol
- Cholan-24-oic acid, 3-hydroxy-, (3.alpha.,5.beta.)-
- Q3323035
- SR-05000000450-2
- SR-05000000450-4
- SR-05000000450-5
- (3beta,5beta,14beta,17alpha)-3-Hydroxycholan-24-Oic Acid
- cho lan-24-oic acid, 3-hydroxy-, (3alpha,5beta)-
- URSODEOXYCHOLIC ACID IMPURITY C [EP IMPURITY]
- Z2216887942
- (R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
- (R)-4-(3alpha-Hydroxy-5beta-androstan-17beta-yl)valeric acid
- 17-.beta.-(1-Methyl-3-carboxypropyl)ethiocholan-3-.alpha.-ol
- 3alpha-Hydroxy-5beta-cholan-24-oic Acid (Lithocholic Acid)
- Cholan-24-oic acid, 3-hydroxy-, (3-.alpha., 5-.beta.)-
- Cholan-24-oic acid, 3-hydroxy-, (3-alpha,5-beta)- (9CI)
- LCA
- (3alpha,5alpha,8alpha,14beta,17alpha)-3-hydroxycholan-24-oic acid
- 17.BETA.-(1-METHYL-3-CARBOXYPROPYL)ETIOCHOLAN-3.ALPHA.-OL
- Lithocholic acid, European Pharmacopoeia (EP) Reference Standard
- (4R)-4-[(1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoic acid
- (4S)-4-((1S,2S,11S,5R,7R,10R,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0. 0<2,7>.0<11,15>]heptadec-14-yl)pentanoic acid
- AC268B61-0548-4391-90E9-546636926870
- Lithocholic acid, 50 mug/mL in methanol, certified reference material
- Ursodeoxycholic Acid EP Impurity C; Chenodeoxycholic Acid EP Impurity C
- 2,8-DIAMINO-9-[3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1H-PURIN-6-ONE
- (3a,5ss)-3-Hydroxycholan-24-oic acid; 17ss-(1-Methyl-3-carboxypropyl)etiocholan-3a-ol; 3-Hydroxycholan-24-oic acid; 3a-Hydroxy-5ss-cholan-24-oate; 3a-Hydroxy-5ss-cholan-24-oic acid; 3a-Hydroxy-5ss-cholanic acid; 3a-Hydroxy-5ss-cholanoic acid; 3a-Hydroxycholanic acid; Lithocholic acid; NSC 683770; Chenodeoxycholic Acid Impurity C; Ursodeoxycholic Acid Impurity C
- (4R)-4-((2S,5R,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-14-yl)pentanoic acid
- (4R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoic acid
- (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoicacid
- 180288-69-1
- 207-099-1
- 3868-32-4
- 4OA